Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

AgEagle Stock Can Rally Despite Obstacles

By Larry Ramer, InvestorPlace Contributor
AgEagle probably won't sell many drones to Amazon for years, but UAVS stock could jump anyway.

Microsoft Is One of the Best Big Tech Stocks

By Ian Bezek, InvestorPlace Contributor
MSFT stock is one of the most appealing big name tech firms now due to its more reasonable valuation and strong growth outlook.

Nokia: OpenRAN Opens Radio’s Pandora’s Box

By Dana Blankenhorn, InvestorPlace Contributor
Open technologies are coming to mobile infrastructure, but possibly in the hands of the cloud czars, which could crush Nokia like a bug.

Metacrine IPO: 5 Things for Potential MTCR Stock Investors to Know

By Nick Clarkson, Web Editor
Did you miss the Metacrine IPO? No worries. Here are a few things investors should know about the MTCR stock moving forward.

The Jury’s Still Out on Norwegian Cruise Line Stock

By Thomas Niel, InvestorPlace Contributor
So, what's the call here with Norwegian Cruise Line stock? If you have a high-risk appetite, and the patience to hold for several years, by all means enter a position. Otherwise, look elsewhere for comeback plays.

Why Slack Stock Risks Another Round of Sharp Selling

By Chris Lau, InvestorPlace Contributor
Slack stock is under pressure after posting another loss and weak billings, suggesting lukewarm results for the rest of the year.

Ericsson Wants to be the Carriers’ Qualcomm in 5G Race

By Dana Blankenhorn, InvestorPlace Contributor
ERIC stock holders should watch for merger talks as Ericsson executives contend with the Cloud Czars who favor open 5G systems.

The Investor’s Guide to Lemonade Stock

By Thomas Yeung, CFA, InvestorPlace Markets Analyst
Is LMND stock another "millionaire-maker" fintech investment? Here's what investors should know about Lemonade, one of 2020's most misunderstood IPOs

Beyond Meat Stock Has Competition and It’s Tasty

By Josh Enomoto, InvestorPlace Contributor
There’s no question that Beyond Meat stock is capitalizing on the enormous popularity of plant-based meat. However, rising competition means that commoditization is a very real threat.

Don’t Buy General Electric Even as the Stock Runs Hot

By InvestorPlace Research Staff
General Electric shares are running higher, but that doesn't make GE stock a buy. Let's break down this name, which continues to struggle.

Why Novartis’ Absence From the Covid-19 Vaccine Race Is a Benefit

By Josh Enomoto, InvestorPlace Contributor
Although it’s one of the major pharmaceuticals, Novartis didn’t directly jump into the vaccine race. That might have been the best move for Novartis stock.

GlaxoSmithKline and Sanofi Stock Rally on EU Vaccine Deal

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
GlaxoSmithKline and Sanofi stock are rallying in early trading on Friday thanks to news they would supply the EU 300 million vaccine doses.

Is Sorrento Stock Really Worth the Speculation?

By Tom Taulli, InvestorPlace Contributor
Sorrento has some potential positive catalysts, especially its Covid-19 diagnostic test. But SRNE stock is really just for the speculative part of your portfolio.

JetBlue Airways Stock Improving, but Remains a High-Risk Bet

By Louis Navellier and the InvestorPlace Research Staff
JetBlue’s focus on domestic travel may mean a better position than airlines that rely on international flights, but JBLU stock remains risky.

AgEagle Aerial Systems Has a Plan That Needs Time to Grow

By Chris Markoch, InvestorPlace Contributor
UAVS stock is one of the hottest penny stock plays of 2020. But if investors are looking for future growth, they need to be in it for the long haul.

Sorrento Therapeutics Fails the Test as a Covid-19 Value Play

By Larry Sullivan, InvestorPlace contributor
Lack of a track record, a lagging Covid-19 test project and executive turmoil make SRNE stock a coronavirus play to avoid.

Volatile Jumia Technologies Stock Will Stay That Way for a While

By Tezcan Gecgil, InvestorPlace Contributor
Share in the African e-commerce company has been hot this year. But JMIA stock is likely to see $5 before $10.

BioNTech Investor Fortunes Rise and Fall on Headlines, Pacts and Funding

By Tezcan Gecgil, InvestorPlace Contributor
BNTX stock is a high-risk high-return investment. BioNTech shares will likely to range-trade in the short run.

Like Oil Prices, Marathon Oil Stock is Going Nowhere Fast

By Chris Markoch, InvestorPlace Contributor
MRO stock isn’t going anywhere anytime soon, so investors don’t have to be in a rush to buy it.
Load More Articles